Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Science Blogs
ACI Profile for Alan Kotok
Featured in Alltop

Preclinical Data Show Promise for Diabetic Eye Drug

Early evidence shows a drug designed as eye drops to treat diabetic macular edema, an eye disease in people with diabetes, permeates the entire eye, including the retina. . . . → Read More: Preclinical Data Show Promise for Diabetic Eye Drug

Computer-Designed Antibodies Target Alzheimer’s Proteins

Researchers in Europe designed antibodies, like those in the immune system, to attack protein deposits in the brain associated with Alzheimer’s disease. . . . → Read More: Computer-Designed Antibodies Target Alzheimer’s Proteins

Engineered Algae Doubles Bio-Oil Content

An industry biotechnology team created a genetically-engineered variety of algae that doubles its oil content without limiting its ability to grow. . . . → Read More: Engineered Algae Doubles Bio-Oil Content

Coalition to Make 10,000 Open-Access Synthetic Genes

A company with a process for creating synthetic DNA and a foundation promoting open access to biotechnology agreed to produce 10,000 synthetic genes made available at no cost to researchers. . . . → Read More: Coalition to Make 10,000 Open-Access Synthetic Genes

$300M Fund to Back European Life Science Companies

A new investment fund plans to invest $300 million in European life science and biotechnology companies in the later stages of their product development. . . . → Read More: $300M Fund to Back European Life Science Companies

First Agricultural Crispr Products Expected by 2020

While the genome editing technique known as Crispr is generating discussion in the health field, its first commercial applications are likely to be in agriculture. . . . → Read More: First Agricultural Crispr Products Expected by 2020

Supreme Court Cuts Biosimilar Waiting Time

The U.S. Supreme Court ruled yesterday that makers of biologic drugs similar to branded originals need not wait an additional 6 months to begin marketing their products. . . . → Read More: Supreme Court Cuts Biosimilar Waiting Time

Engineered Immune Cells to be Explored for Solid Tumors

A cancer research center and biotechnology company will examine genetically engineered immune system cells as possible treatments for solid tumor cancers. . . . → Read More: Engineered Immune Cells to be Explored for Solid Tumors

Univ. Spin-Off Discovering New Antibiotics

A new enterprise founded by three microbiologists at Harvard Medical School is licensing the founders’ research to find treatments for antibiotic-resistant bacteria. . . . → Read More: Univ. Spin-Off Discovering New Antibiotics

Bacteria Engineered to Act as Long-Term Gut Sensors

A bioengineering team developed a synthetic form of bacteria that live in the gut, and detect inflammation in lab mice for 6 months. . . . → Read More: Bacteria Engineered to Act as Long-Term Gut Sensors